SCHEMBL7414529

SCHEMBL7414529

CSCCCC(=O)N(O)NC(=O)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.40
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
NAMPT P43490 1/20 0.39
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
KMT2A Q03164 2/20 0.38
ALDH1A1 P00352 2/20 0.38
MEN1 O00255 1/20 0.38
CRHBP P24387 1/20 0.38
CRHR2 Q13324 1/20 0.38
GAA P10253 2/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
LMNA P02545 1/20 0.37
RECQL P46063 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7417079 0.73 SMN1; SMN2 (0.47) POLBTDP1L3MBTL1NPC1RAB9A
SCHEMBL7413034 0.72 RAB9A (0.43) POLBTDP1NPC1RAB9AALDH1A1
SCHEMBL15341665 0.72 NAAA (0.63) POLBL3MBTL1NAMPTNPC1RAB9A
SCHEMBL17577532 0.71 NAAA (0.66) POLBL3MBTL1NAMPTNPC1RAB9A
SCHEMBL6009689 0.69 TDP1 (0.61) POLBTDP1L3MBTL1GAACYP3A4
SCHEMBL4347123 0.68 RAB9A (0.68) POLBL3MBTL1NPC1RAB9AALDH1A1
SCHEMBL28460956 0.68 L3MBTL1 (0.51) POLBTDP1L3MBTL1GAACYP3A4
SCHEMBL22187027 0.67 HDAC4 (0.65) L3MBTL1NPC1CYP3A4SMN1; SMN2
SCHEMBL21226237 0.67 MAPT (0.59) POLBTDP1L3MBTL1NPC1RAB9A
SCHEMBL28981637 0.67 L3MBTL1 (0.50) POLBTDP1L3MBTL1GAALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6218389-B1 FOR THERAPY AND PROPHYLAXIS OF ARTHRITIS, CANCER, CARDIOVASCULAR DISORDERS; SKIN DISORDERS; OCULAR DISORDERS; INFLAMMATION AND GUM DISEASES, MULTIPLE SCLEROSIS, CACHEXIA, PREVENTING LOOSENING OF PROSTHETIC DEVICES THE PROCTER & GAMBLE CO. 2001-04-17 US disclosed
EP-1009737-A2 SULFONYLAMINO SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 2000-06-21 EP disclosed
WO-1999006340-A2 SULFONYLAMINO SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 1999-02-11 WO disclosed